查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1955106

智慧吸入器市場：市場規模、佔有率、成長率、行業分析、按類型、應用和地區的洞察以及未來預測（2026-2034年）

Smart Inhalers Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 135 Pages | 商品交期: 請詢問到貨日

價格

智慧吸入器市場的成長要素

受數位藥物傳輸系統技術進步和呼吸系統疾病日益成長的推動，全球智慧吸入器市場正經歷顯著成長。根據 Fortune Business Insights 預測，該市場規模在2025年達到 2.2198億美元，預計2026年達到 3.1411億美元。預計到2034年，該產業規模將飆升至 53.4562億美元，在2026年至2034年的預測期內，年複合成長率將達到 42.52%。北美地區預計將在2025年佔據市場主導地位，市場佔有率將達到 67.74%，這主要得益於數位醫療的普及、政府的支持性政策以及公共和私人對智慧吸入器技術的大量投資。

市場概況及成長要素

智慧吸入器是一種內建感測器的醫療設備，可連接到智慧型手機和其他數位平台，用於監測患者的健康狀況，特別是患有氣喘和慢性阻塞性肺病（COPD）等疾病的患者。這些設備可以追蹤藥物使用情況、劑量和患者依從性，並就空氣污染和花粉症等環境因素發出警報。

慢性呼吸系統疾病盛行率的上升以及人們對預防醫學日益重視是推動市場成長的主要因素。例如，美國疾病管制與預防中心（CDC）的資料顯示，超過2500萬美國人患有氣喘，凸顯了需要精準藥物管理的患者群體不斷擴大。此外，智慧吸入器的引進已證明可以減少住院和門診就診次數，改善治療效果並加速市場滲透。

市場趨勢

智慧吸入器市場正經歷數位化技術的快速融合。定量噴霧吸入器（MDI）和乾粉吸入器（DPI）等設備現在都配備了藍牙感測器，可提供劑量監測和提醒功能。主要企業正大力投資研發，以推出基於MDI的創新智慧吸入器。例如，2024年11月，Lupin公司發布了ADHERO，這是一款針對急性呼吸系統疾病患者的智慧MDI設備，可提高患者的用藥依從性並實現使用監測。

市場限制因素

儘管存在這些優勢，市場成長仍面臨挑戰。尤其是在發展中地區，人們對數位吸入器的認知度仍然較低，傳統吸入器仍被用作替代方案。此外，新興經濟體的技術壁壘和可及性問題也可能減緩數位吸入器的普及。

細分市場分析

  • 依產品類別分類：預計到2026年，基於定量吸入器（MDI）的智慧吸入器將佔據68.86%的市場佔有率（2.163億美元），憑藉其卓越的劑量監測和控制能力，保持主導地位。雖然基於乾粉吸入器（DPI）的吸入器保持著穩定的市場佔有率，但劑量變異性等技術問題正透過持續的研發得到解決。
  • 疾病細分：2026年，氣喘領域將引領市場，佔據57.99%的市場佔有率（1.8213億美元），主要得益於全球氣喘盛行率的上升。慢性阻塞性肺病（COPD）領域預計將保持穩定成長，這主要得益於智慧吸入器在日常疾病監測中的應用。
  • 通路：醫院藥房憑藉其便利性和與生產商的合作關係佔據主導地位。同時，隨著非處方數位吸入器獲得FDA核准，零售藥局預計到2026年將佔據37.70%的市場佔有率（1.1841億美元）。

區域洞察

北美地區在2025年以1.5037億美元的市場規模引領全球市場，主要得益於醫療保健數位化、有利的政策以及強勁的公私投資。預計到2026年，美國市場規模將達到1.996億美元。歐洲市場呈現穩定成長態勢，預計2026年，英國和德國市場規模將分別達到1,860萬美元和755萬美元，主要得益於數位化醫療設備的普及應用。亞太地區預計將經歷快速成長，預計到2026年，日本市場規模將達到1,358萬美元，中國將達到562萬美元，印度將達到398萬美元，這主要得益於供應商滲透率的提高和醫療保健IT領域投資的增加。

主要企業及趨勢

市場仍在發展中，但競爭異常激烈，主要參與者包括Adherium、Propeller Health、Cohero Health Inc.、GlaxoSmithKline、AstraZeneca、Novartis AG、3M、Teva Pharmaceuticals、Vectura Group。每家公司都專注於研發、數位整合和策略合作，以鞏固其市場地位。關鍵進展包括Propeller Health於2020年與Novartis合作，為日本市場推出數位健康平台；以及AptarGroup與Sonmol在中國數位療法業務領域展開合作。同樣在2020年，Teva Respiratory的「ArmonAir Digihaler」獲得了FDA核准，這是一款用於氣喘患者的擴展型數位吸入解決方案。

目錄

第1章 引言

第2章 執行摘要

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機會

第4章 主要考察

  • 近期產業趨勢：企業合併等
  • 主要國家的監管狀況
  • 與智慧吸入器相關的技術進步
  • 智慧吸入器產業背景
  • 主要行業趨勢
  • 新產品發布

第5章 全球智慧吸入器市場分析、洞察與預測（2021-2034）

  • 主要分析結果/總結
  • 市場分析、洞察與預測：依產品分類
    • 乾粉吸入器（DPI）式吸入器
    • 定量噴霧吸入器（MDI）式吸入器
  • 市場分析、洞察與預測：依疾病類型分類
    • 氣喘
    • 慢性阻塞性肺病（COPD）
  • 市場分析、洞察與預測：依通路分類
    • 醫院藥房
    • 零售藥房
    • 線上管道
  • 市場分析、洞察與預測：依地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 世界其他地區（RoW）

第6章 北美智慧吸入器市場分析：洞察與預測（2021-2034）

  • 國家
    • 美國
    • 加拿大

第7章 歐洲智慧吸入器市場分析：洞察與預測（2021-2034）

  • 國家
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他歐洲國家

第8章 亞太地區智慧吸入器市場分析：洞察與預測（2021-2034）

  • 國家
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 其他亞太地區

第9章 其他地區（ROW）智慧吸入器市場分析：洞察與預測（2021-2034年）

第10章 競爭分析

  • 主要行業趨勢
  • 全球市場佔有率分析（2021）
  • 競爭儀錶板
  • 主要企業比較分析
  • 公司簡介
    • Adherium
    • Propeller Health
    • Cohero Health Inc.
    • GlaxoSmithKline
    • AstraZeneca plc
    • Novartis AG
    • 3M Company
    • Teva Pharmaceuticals
    • Vectura Group
    • Others

第11章 策略建議

Product Code: FBI102705

Growth Factors of smart inhalers Market

The global smart inhalers market is witnessing significant growth, driven by technological advancements in digital drug delivery systems and the rising prevalence of respiratory diseases. According to Fortune Business Insights, the market was valued at USD 221.98 million in 2025, is projected to reach USD 314.11 million in 2026, and is expected to soar to USD 5,345.62 million by 2034, exhibiting a robust CAGR of 42.52% during the forecast period from 2026 to 2034. North America dominated the market in 2025 with a 67.74% share, driven by digital healthcare adoption, supportive government policies, and significant public and private funding for smart inhaler technologies.

Market Overview and Growth Drivers

Smart inhalers are medical devices integrated with sensors that connect to smartphones or other digital platforms to monitor patients' health, particularly for conditions such as asthma and chronic obstructive pulmonary disease (COPD). These devices track medication usage, dosage, and patient adherence, while providing alerts for environmental triggers like pollution or high pollen counts.

The rising prevalence of chronic respiratory diseases and increased focus on preventive care are key drivers of market growth. For instance, as per CDC data, over 25 million Americans suffer from asthma, highlighting a growing patient pool requiring precise medication management. Moreover, the adoption of smart inhalers has been shown to reduce hospitalization and doctor visits, enhancing procedural outcomes and encouraging broader market adoption.

Market Trends

The smart inhalers market is experiencing rapid digital integration. Devices like metered-dose inhalers (MDI) and dry powder inhalers (DPI) now include Bluetooth-enabled sensors for dose monitoring and reminders. Major companies are investing heavily in R&D to launch innovative MDI-based smart inhalers. For instance, in November 2024, Lupin introduced ADHERO, a smart MDI device for acute respiratory patients to improve adherence and monitor usage.

Market Restraints

Despite the advantages, market growth faces challenges. Manual inhalers continue to serve as substitutes, particularly in developing regions where awareness of digital inhalers remains limited. Additionally, technical and accessibility barriers in emerging economies may slow adoption.

Segment Analysis

  • By Product: MDI-based smart inhalers dominated in 2026 with 68.86% market share (USD 216.3 million), owing to superior dosage monitoring and control features. DPI-based inhalers maintain a stable market presence, though technical issues like inconsistent dosage are being addressed through ongoing R&D.
  • By Disease Indication: The asthma segment led the market in 2026, accounting for 57.99% share (USD 182.13 million) due to increasing prevalence globally. The COPD segment is projected to grow steadily, supported by the adoption of smart inhalers for regular disease monitoring.
  • By Distribution Channel: Hospital pharmacies hold a dominant position due to accessibility and partnerships with manufacturers, while retail pharmacies achieved 37.70% share (USD 118.41 million) in 2026, aided by FDA approvals for over-the-counter digital inhalers.

Regional Insights

North America led the global market in 2025 with USD 150.37 million, driven by healthcare digitalization, favorable policies, and strong private and public investments. The U.S. market is projected to reach USD 199.6 million by 2026. Europe shows steady growth, with the U.K. and Germany markets projected at USD 18.6 million and USD 7.55 million in 2026, respectively, due to the adoption of digital medical devices. Asia Pacific is anticipated to grow rapidly, with Japan at USD 13.58 million, China at USD 5.62 million, and India at USD 3.98 million by 2026, supported by increasing vendor penetration and healthcare IT investments.

Key Industry Players and Developments

The market is nascent yet competitive, with key players such as Adherium, Propeller Health, Cohero Health Inc., GlaxoSmithKline, AstraZeneca, Novartis AG, 3M, Teva Pharmaceuticals, and Vectura Group. Companies are focusing on R&D, digital integration, and strategic collaborations to enhance their market position. Notable developments include Propeller Health's partnership with Novartis in 2020 to introduce a digital health platform in Japan and AptarGroup's collaboration with Sonmol for digital therapies in China. Teva Respiratory received FDA approval in 2020 for ArmonAir Digihaler, expanding digital inhalation solutions for asthma patients.

Conclusion

The global smart inhalers market is poised for exponential growth between 2025 and 2034, driven by rising respiratory disease prevalence, technological advancements, and increasing adoption of digital health devices. While the presence of manual inhalers and limited awareness in developing regions may restrain growth, innovations in MDI-based devices, hospital and retail pharmacy partnerships, and supportive regulatory frameworks are expected to significantly accelerate market adoption. North America remains the dominant market, while Asia Pacific offers substantial growth potential owing to emerging economies and digital healthcare expansion. The market trajectory highlights the critical role of smart inhalers in improving patient adherence, reducing healthcare costs, and enhancing respiratory disease management worldwide.

Segmentation By Product

  • Dry Powder Inhaler (DPI)- based Inhalers
  • Metered Dose Inhaler (MDI)- based Inhalers

By Disease indication

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Channel

By Geography

  • North America (U.S. and Canada)
  • Europe (U.K., Germany, France, Italy, Spain, and Rest of Europe)
  • Asia-Pacific (Japan, China, India, Australia, and Rest of Asia- Pacific)
  • Rest of the world (Row)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities

4. Key Insights

  • 4.1. Recent Industry Developments Such as Mergers & Acquisitions
  • 4.2. Regulatory Scenario for Key Countries
  • 4.3. Technological Advancements Pertaining to Smart Inhalers
  • 4.4. Industry Background Pertaining to Smart Inhalers
  • 4.5. Key Industry Trends
  • 4.6. New Product Launch

5. Global Smart Inhalers Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Key Findings / Summary
  • 5.2. Market Analysis, Insights and Forecast - By Product
    • 5.2.1. Dry Powder Inhaler (DPI)- based Inhalers
    • 5.2.2. Metered Dose Inhaler (MDI)- based Inhalers
  • 5.3. Market Analysis, Insights and Forecast - By Disease indication
    • 5.3.1. Asthma
    • 5.3.2. Chronic Obstructive Pulmonary Disease (COPD)
  • 5.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 5.4.1. Hospital Pharmacies
    • 5.4.2. Retail Pharmacies
    • 5.4.3. Online Channel
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Rest of the World (RoW)

6. North America Smart Inhalers Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Key Findings / Summary
  • 6.2. Market Analysis, Insights and Forecast - By Product
    • 6.2.1. Dry Powder Inhaler (DPI)- based Inhalers
    • 6.2.2. Metered Dose Inhaler (MDI)- based Inhalers
  • 6.3. Market Analysis, Insights and Forecast - By Disease indication
    • 6.3.1. Asthma
    • 6.3.2. Chronic Obstructive Pulmonary Disease (COPD)
  • 6.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 6.4.1. Hospital Pharmacies
    • 6.4.2. Retail Pharmacies
    • 6.4.3. Online Channel
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Smart Inhalers Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Key Findings / Summary
  • 7.2. Market Analysis, Insights and Forecast - By Product
    • 7.2.1. Dry Powder Inhaler (DPI)- based Inhalers
    • 7.2.2. Metered Dose Inhaler (MDI)- based Inhalers
  • 7.3. Market Analysis, Insights and Forecast - By Disease indication
    • 7.3.1. Asthma
    • 7.3.2. Chronic Obstructive Pulmonary Disease (COPD)
  • 7.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.4.1. Hospital Pharmacies
    • 7.4.2. Retail Pharmacies
    • 7.4.3. Online Channel
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub Region
    • 7.5.1. U.K.
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Spain
    • 7.5.5. Italy
    • 7.5.6. Rest of Europe

8. Asia Pacific Smart Inhalers Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Key Findings / Summary
  • 8.2. Market Analysis, Insights and Forecast - By Product
    • 8.2.1. Dry Powder Inhaler (DPI)- based Inhalers
    • 8.2.2. Metered Dose Inhaler (MDI)- based Inhalers
  • 8.3. Market Analysis, Insights and Forecast - By Disease indication
    • 8.3.1. Asthma
    • 8.3.2. Chronic Obstructive Pulmonary Disease (COPD)
  • 8.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 8.4.1. Hospital Pharmacies
    • 8.4.2. Retail Pharmacies
    • 8.4.3. Online Channel
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub Region
    • 8.5.1. Japan
    • 8.5.2. China
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Rest of Asia Pacific

9. Rest of the World Smart Inhalers Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Key Findings / Summary
  • 9.2. Market Analysis, Insights and Forecast - By Product
    • 9.2.1. Dry Powder Inhaler (DPI)- based Inhalers
    • 9.2.2. Metered Dose Inhaler (MDI)- based Inhalers
  • 9.3. Market Analysis, Insights and Forecast - By Disease indication
    • 9.3.1. Asthma
    • 9.3.2. Chronic Obstructive Pulmonary Disease (COPD)
  • 9.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 9.4.1. Hospital Pharmacies
    • 9.4.2. Retail Pharmacies
    • 9.4.3. Online Channel

10. Competitive Analysis

  • 10.1. Key Industry Developments
  • 10.2. Global Market Share Analysis (2021)
  • 10.3. Competition Dashboard
  • 10.4. Comparative Analysis - Major Players
  • 10.5. Company Profiles
    • 10.5.1. Adherium
      • 10.5.1.1. Overview,
      • 10.5.1.2. Products & services,
      • 10.5.1.3. SWOT analysis,
      • 10.5.1.4. Recent developments,
      • 10.5.1.5. strategies,
      • 10.5.1.6. financials (based on availability)
    • 10.5.2. Propeller Health
      • 10.5.2.1. Overview,
      • 10.5.2.2. Products & services,
      • 10.5.2.3. SWOT analysis,
      • 10.5.2.4. Recent developments,
      • 10.5.2.5. strategies,
      • 10.5.2.6. financials (based on availability)
    • 10.5.3. Cohero Health Inc.
      • 10.5.3.1. Overview,
      • 10.5.3.2. Products & services,
      • 10.5.3.3. SWOT analysis,
      • 10.5.3.4. Recent developments,
      • 10.5.3.5. strategies,
      • 10.5.3.6. financials (based on availability)
    • 10.5.4. GlaxoSmithKline
      • 10.5.4.1. Overview,
      • 10.5.4.2. Products & services,
      • 10.5.4.3. SWOT analysis,
      • 10.5.4.4. Recent developments,
      • 10.5.4.5. strategies,
      • 10.5.4.6. financials (based on availability)
    • 10.5.5. AstraZeneca plc
      • 10.5.5.1. Overview,
      • 10.5.5.2. Products & services,
      • 10.5.5.3. SWOT analysis,
      • 10.5.5.4. Recent developments,
      • 10.5.5.5. strategies,
      • 10.5.5.6. financials (based on availability)
    • 10.5.6. Novartis AG
      • 10.5.6.1. Overview,
      • 10.5.6.2. Products & services,
      • 10.5.6.3. SWOT analysis,
      • 10.5.6.4. Recent developments,
      • 10.5.6.5. strategies,
      • 10.5.6.6. financials (based on availability)
    • 10.5.7. 3M Company
      • 10.5.7.1. Overview,
      • 10.5.7.2. Products & services,
      • 10.5.7.3. SWOT analysis,
      • 10.5.7.4. Recent developments,
      • 10.5.7.5. strategies,
      • 10.5.7.6. financials (based on availability)
    • 10.5.8. Teva Pharmaceuticals
      • 10.5.8.1. Overview,
      • 10.5.8.2. Products & services,
      • 10.5.8.3. SWOT analysis,
      • 10.5.8.4. Recent developments,
      • 10.5.8.5. strategies,
      • 10.5.8.6. financials (based on availability)
    • 10.5.9. Vectura Group
      • 10.5.9.1. Overview,
      • 10.5.9.2. Products & services,
      • 10.5.9.3. SWOT analysis,
      • 10.5.9.4. Recent developments,
      • 10.5.9.5. strategies,
      • 10.5.9.6. financials (based on availability)
    • 10.5.10. Others
      • 10.5.10.1. Overview,
      • 10.5.10.2. Products & services,
      • 10.5.10.3. SWOT analysis,
      • 10.5.10.4. Recent developments,
      • 10.5.10.5. strategies,
      • 10.5.10.6. financials (based on availability)

11. Strategic Recommendations

List of Tables

  • Table 1: Global Smart Inhalers Market Revenue (US$ Mn) Forecast, by Product, 2021-2034
  • Table 2: Global Smart Inhalers Market Revenue (US$ Mn) Forecast, by Disease indication, 2021-2034
  • Table 3: Global Smart Inhalers Market Revenue (US$ Mn) Forecast, by Distribution Channel 2021-2034
  • Table 4: Global Smart Inhalers Market Revenue (US$ Mn) Forecast, by Region, 2021-2034
  • Table 5: North America Smart Inhalers Market Revenue (US$ Mn) Forecast, by Product, 2021-2034
  • Table 6: North America Smart Inhalers Market Revenue (US$ Mn) Forecast, by Disease indication, 2021-2034
  • Table 7: North America Smart Inhalers Market Revenue (US$ Mn) Forecast, by Distribution Channel 2021-2034
  • Table 8: North America Smart Inhalers Market Revenue (US$ Mn) Forecast, By Country, 2021-2034
  • Table 9: Europe Smart Inhalers Market Revenue (US$ Mn) Forecast, by Product, 2021-2034
  • Table 10: Europe Smart Inhalers Market Revenue (US$ Mn) Forecast, by Disease indication, 2021-2034
  • Table 11: Europe Smart Inhalers Market Revenue (US$ Mn) Forecast, by Distribution Channel 2021-2034
  • Table 12: Europe Smart Inhalers Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Asia Pacific Smart Inhalers Market Revenue (US$ Mn) Forecast, by Product, 2021-2034
  • Table 14: Asia Pacific Smart Inhalers Market Revenue (US$ Mn) Forecast, by Disease indication, 2021-2034
  • Table 15: Asia Pacific Smart Inhalers Market Revenue (US$ Mn) Forecast, by Distribution Channel 2021-2034
  • Table 16: Asia Pacific Smart Inhalers Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034
  • Table 17: Rest of the World (RoW) Smart Inhalers Market Revenue (US$ Mn) Forecast, by Product, 2021-2034
  • Table 18: Rest of the World (RoW) Smart Inhalers Market Revenue (US$ Mn) Forecast, by Disease indication, 2021-2034
  • Table 19: Rest of the World (RoW) Smart Inhalers Market Revenue (US$ Mn) Forecast, by Distribution Channel 2021-2034

List of Figures

  • Figure 1: Global Smart Inhalers Market Revenue Breakdown (US$ Mn, %) by Region, 2021 & 2034
  • Figure 2: Global Smart Inhalers Market Value Share (%), by Product, 2021 & 2034
  • Figure 3: Global Smart Inhalers Market Forecast (US$ Mn), by Dry Powder Inhaler (DPI)- based Inhalers,2021-2034
  • Figure 4: Global Smart Inhalers Market Forecast (US$ Mn), by Metered Dose Inhaler (MDI)- based Inhalers,2021-2034
  • Figure 5: Global Smart Inhalers Market Value Share (%), by Disease indication, 2021 & 2034
  • Figure 6: Global Smart Inhalers Market Forecast (US$ Mn), by Asthma, 2021-2034
  • Figure 7: Global Smart Inhalers Market Forecast (US$ Mn), by Chronic Obstructive Pulmonary Disease (COPD), 2021-2034
  • Figure 8: Global Smart Inhalers Market Value Share (%), by Distribution Channel 2021 & 2034
  • Figure 9: Global Smart Inhalers Market Forecast (US$ Mn), by Hospital Pharmacies, 2021-2034
  • Figure 10: Global Smart Inhalers Market Forecast (US$ Mn), by Retail Pharmacies 2021-2034
  • Figure 11: Global Smart Inhalers Market Forecast (US$ Mn), by Online Channel, 2021-2034
  • Figure 12: Global Smart Inhalers Market Value (US$ Mn), by Region, 2021 & 2034
  • Figure 13: North America Smart Inhalers Market Value (US$ Mn), by Product, 2021 & 2034
  • Figure 14: North America Smart Inhalers Market Value Share (%), by Product, 2021
  • Figure 15: North America Smart Inhalers Market Value (US$ Mn), by Disease indication, 2021 & 2034
  • Figure 16: North America Smart Inhalers Market Value Share (%), by Disease indication, 2021
  • Figure 17: North America Smart Inhalers Market Value (US$ Mn), by Distribution Channel 2021 & 2034
  • Figure 18: North America Smart Inhalers Market Value Share (%), by Distribution Channel 2021
  • Figure 19: North America Smart Inhalers Market Value (US$ Mn), By Country, 2021 & 2034
  • Figure 20: North America Smart Inhalers Market Value Share (%), By Country, 2021
  • Figure 21: Europe Smart Inhalers Market Value (US$ Mn), by Product, 2021 & 2034
  • Figure 22: Europe Smart Inhalers Market Value Share (%), by Product, 2021
  • Figure 23: Europe Smart Inhalers Market Value (US$ Mn), by Disease indication, 2021 & 2034
  • Figure 24: Europe Smart Inhalers Market Value Share (%), by Disease indication, 2021
  • Figure 25: Europe Smart Inhalers Market Value (US$ Mn), by Distribution Channel 2021 & 2034
  • Figure 26: Europe Smart Inhalers Market Value Share (%), by Distribution Channel 2021
  • Figure 27: Europe Smart Inhalers Market Value (US$ Mn), By Country/ Sub-region, 2021 & 2034
  • Figure 28: Europe Smart Inhalers Market Value Share (%), By Country/ Sub-region, 2021
  • Figure 29: Asia Pacific Smart Inhalers Market Value (US$ Mn), by Product, 2021 & 2034
  • Figure 30: Asia Pacific Smart Inhalers Market Value Share (%), by Product, 2021
  • Figure 31: Asia Pacific Smart Inhalers Market Value (US$ Mn), by Disease indication, 2021 & 2034
  • Figure 32: Asia Pacific Smart Inhalers Market Value Share (%), by Disease indication, 2021
  • Figure 33: Asia Pacific Smart Inhalers Market Value (US$ Mn), by Distribution Channel 2021 & 2034
  • Figure 34: Asia Pacific Smart Inhalers Market Value Share (%), by Distribution Channel 2021
  • Figure 35: Asia Pacific Smart Inhalers Market Value (US$ Mn), By Country/ Sub-region, 2021 & 2034
  • Figure 36: Asia Pacific Smart Inhalers Market Value Share (%), By Country/ Sub-region, 2021
  • Figure 37: Rest of the World (RoW) Smart Inhalers Market Value (US$ Mn), by Product, 2021 & 2034
  • Figure 38: Rest of the World (RoW) Smart Inhalers Market Value Share (%), by Product, 2021
  • Figure 39: Rest of the World (RoW) Smart Inhalers Market Value (US$ Mn), by Disease indication, 2021 & 2034
  • Figure 40: Rest of the World (RoW) Smart Inhalers Market Value Share (%), by Disease indication, 2021
  • Figure 41: Rest of the World (RoW) Smart Inhalers Market Value (US$ Mn), by Distribution Channel 2021 & 2034
  • Figure 42: Rest of the World (RoW) Smart Inhalers Market Value Share (%), by Distribution Channel 2021
  • Figure 43: Global Smart Inhalers Market Share (%), By Company, 2021